<!DOCTYPE html>
<html lang="en">
    
    <head>
        
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        
        <title>Concor - Undesirable Effects</title>
        
        <!-- Bootstrap's Core CSS -->
        <link rel="stylesheet" href="../assets/css/bootstrap.min.css">
        
        <!-- Font Awesome Icon Library -->
        <link rel="stylesheet" href="../assets/css/font-awesome.min.css">
        
        <!-- IE Viewport CSS Fix -->
        <link rel="stylesheet" href="../assets/css/ie-viewport-fix.css">
        
        <!-- Custom CSS -->
        <link rel="stylesheet" href="../assets/css/style.css">
        
        <!-- Google Fonts -->
        <link href="https://fonts.googleapis.com/css?family=Open+Sans:300,400,700" rel="stylesheet">
        
        <!-- HTML5 Shiv and Respond.JS - HTML5 and CSS3 Media Queries for Legacy Browsers -->
        <!--[if lt IE 9]>
            <script src="assets/js/html5shiv.min.js"></script>
            <script src="assets/js/html5shiv-printshiv.min.js"></script>
            <script src="assets/js/respond.js"></script>
        <![endif]-->
        
    </head>
    
    <body>
        
            <div class="container">
                <div class="row">
                    
                    <div class="col-md-12">
                            <h3 class="head-title">Undesirable Effects / Effects On Ability To Drive And Use Machines</h3>
                        <div class="content">
                            <p>The undesirable effects that may occur after taking Concor are listed below. Their frequencies are defined as follows: very common: > 10%; common: ≥ 1%, &lt; 10%; uncommon: ≥ 0.1%, &lt; 1%; rare: ≥ 0.01%, &lt; 0.1%; very rare: &lt; 0.01%.</p>
                        </div>
                        <p>- Metabolism And Nutrition Disorders</p>
                            <ul>
                                <li>Rare: Hypertriglyceridemia</li>
                            </ul>
                        <p>- Psychiatric disorders</p>
                            <ul>
                                <li>Uncommon: Sleep disturbances, depression</li>
                                <li>Rare: Increased dream activity, hallucinations</li>
                            </ul>
                        <p>- Nervous System Disorders</p>
                            <ul>
                                <li>Common: Fatigue, dizziness, headaches and sweating. In patients with hypertension or angina, these effects occur particularly at the start of treatment, are generally mild in nature and usually disappear after 1-2 weeks of treatment.Numbness and a sensation of cold in the extremities, asthenia (in patients with chronic heart  failure).</li>
                                <li>Uncommon: Asthenia (in patients with hypertension or angina).</li>
                                <li>Rare: Dry mouth.</li>
                            </ul>
                        <p>- Eye disorders</p>
                        <ul>
                            <li>Rare: Reduced lacrimation (relevant if the patient wears contact lenses)</li>
                            <li>Very rare: Conjunctivitis</li>
                        </ul>
                        <p>- Ear And Labyrinth Disorders</p>
                            <ul>
                                <li>Rare: Impaired hearing</li>
                            </ul>
                        <p>- Cardiovascular Disorders</p>
                            <ul>
                                <li>Very common: Bradycardia (in patients with chronic heart failure).</li>
                                <li>Common: Hypotension (especially in patients with chronic heart failure), exacerbation of heart failure (in patients with chronic heart failure).</li>
                                <li>Uncommon: Bradycardia (in patients with hypertension or angina), exacerbation of heart failure (in patients with hypertension or angina), atrioventricular conduction disturbances. Patients with peripheral circulatory disorders (intermittent claudication, Raynaud's syndrome) may find that their symptoms are exacerbated.</li>
                                <li>Frequency not known: Syncope</li>
                            </ul>
                        <p>- Gastrointestinal Disorders</p>
                        <ul>
                            <li>Common: Nausea, vomiting, diarrhoea, constipation, abdominal pain</li>
                        </ul>
                        <p>- Hepatic Disorders</p>
                        <ul>
                            <li>Rare: Elevated liver enzymes (AST, ALT), hepatitis, jaundice.</li>
                        </ul>
                        <p>- Skin And Subcutaneous Tissue Disorders</p>
                        <ul>
                            <li>Rare: Hypersensitivity reactions (pruritus, redness, rash)</li>
                            <li>Very rare: Alopecia. Psoriasis or a rash similar to psoriasis may be caused or exacerbated by β-blockers.</li>
                        </ul>
                        <p>- Musculoskeletal And Connective Tissue Disorders</p>
                        <ul>
                            <li>Uncommon: Muscle weakness and cramps.</li>
                        </ul>
                        <p>- Urogenital Disorders</p>
                        <ul>
                            <li>Rare: Potency disorders</li>
                        </ul>
                        <p>- Effects On Ability To Drive And Use Machines</p>
                        <ul>
                            <li> Individually different reactions to blood pressure reduction may impair the ability to actively participate in road traffic or operate machines. This applies to a greater extent at the start of therapy, when switching to another medicine and in combination with alcohol. However, specific studies have shown that the selective β1-receptor blocker bisoprolol is unlikely to directly impair alertness.</li>
                        </ul>
                    </div><!--- End Of Container --->
                </div><!-- End Of Row -->
            </div><!-- End Of Container -->
        
    
        <!-- Scripts -->
        
        <!-- jQuery -->
        <script src="../assets/js/jquery.min.js"></script>
        
        <!-- Bootstrap's JS -->
        <script src="../assets/js/bootstrap.min.js"></script>
        
        <!-- IE Viewport JS Fix -->
        <script src="../assets/js/ie-viewport-fix.js"></script>
        
        <!-- Custom Script -->
        <script src="../assets/js/script.js"></script>
    </body>
</html>